GreenLight Laser Therapy

Designed to Redefine and Create a New Standard of Care

Inspired by principles of physics and the belief that clinical outcomes and patient safety should be the sole drivers in a treatment selection, the GreenLight PV® laser system has paved the way for creating a new standard of care in the treatment of BPH.

Clinical Excellence without Compromise

Dramatic urine flow improvement

  • 170%-252% improvement at 3 years 4

Less risk than TURP

  • No significant risk of TUR syndrome, fluid absorption or blood transfusion 12, 13, 14, 15

A definitive, long lasting treatment

  • 2.2% re-operations after one year follow up (BNS and stricture) 13

Widest patient selection

  • Patients in retention 16
  • Wide range of gland size and morphology 5, 17, 18
  • Able to treat patients on anti-coagulants 6, 14, 17

Mild and short-lived irritative symptoms

  • 9% transient dysuria < 10 days 15
  • 9% mild to moderate transient hematuria < 10 days 15

No prolonged catheterization

  • Mean catheterization time is 14.1 hours 12
  • 2.2% rate of UTI 12

Low rate of sexual side-effects

  • Less than 1% reported cases of erectile dysfunction 4, 12
  • 36% rate of retrograde ejaculation at 1 year 15

Outpatient Procedure for healthy patients

  • Quick return to normal activities

Clinical Adoption

  • Over 200,000 procedures worldwide
  • 49 peer-reviewed articles 9

Specifications

GreenLight PV

Click here to view the GreenLight PV ™ Laser System Specifications.

GreenLight HPS

Click here to view the GreenLight HPS™ Laser Platform Specifications.

GreenLight HPS™

Introducing the new GreenLight HPS

A high performance system designed to move you quickly, comfortably and intelligently to the site of service of your preference.

Designed for Function and Form

GreenLight Laser Therapy
High Speed Performance with Precision

Delivers consistent and sustainable vaporization over a large range of working distances, anatomy configurations and tissue composition. Allows for shorter procedure time and more efficient treatment of large glands.

Intelligent Design

A wide range of power settings allow the surgeon to match the nuance of each surgical situation, from anatomy configuration to tissue composition, with TURP-like control over Vaporization/Coagulation and Ready/Standby modes.

Standard Electrical Utilities

Plug and Play Operation auto-adjusts line voltage to provide easy access to any O.R., any time.

Air Cooled System

Eliminates the need for external water connections.

State-of-the-Art Modular Construction

Reliable cutting edge technology sets a new industry standard for high performance with easy care maintenance features.

Features

GreenLight screen
Touch Screen
User-activated screen allows for easy adjustments of power and mode settings. Pre-set vaporization and coagulation power levels provide hands-free mode selection while lasing.
PVP googles
Clear View Glasses
Near-clear glasses provide eye protection while optimizing visualization.
greenlight
Precision Beam
A low divergence precision beam allows rapid vaporization over a large range of working distances. Unique design eliminates backscatter to protect vital tissue structures.
HPS speaker
Voice Alert System
Automated voice confirmation alerts surgical staff to system status.
PVP pedal
Dual Foot Switch
QuickSwitch pedal offers easy TURP-like foot control of Vaporization/Coagulation and Standby/Ready modes. Surgeon controlled operation expedites procedure time.

Specifications

Click here to view the GreenLight HPS™ Laser Platform Specifications.

Brochures and Newsletters

Brochures:
Newsletters:

Reference & Partial Bibliography

1. Bouchier-Hayes DM, Anderson P, Van Appledorn S, Bugeja P, Costello AJ. KTP laser versus transurethral resection: early results of a randomized trial. J Endourol. 2006 Aug;20(8):580-5.

2. Karatas OF, Tasci A, Tugcu V. Erectile functions in BPH patients after photoselective vaporisation of the prostate laser surgery. Eur Urol 2006;5(2 suppl.):272 abstract 997. EAU Meeting, Apr 5-8,2006 Paris, France.

3. Malek RS, Kuntzman RS, Barrett DM. High power potassium-titanyl-phosphate laser vaporization prostatectomy. J Urol. 2000 Jun;163(6):1730-3.

4. Malek RS, Kuntzman RS, Barrett DM.Photoselective potassium-titanyl-phosphate laser vaporization of the benign obstructive prostate: observations on long-term outcomes. J Urol. 2005 Oct;174(4 Pt 1):1344-8.

5. Malek RS, Barrett DM, Kuntzman RS. High-power potassium-titanyl-phosphate (KTP/532) laser vaporization prostatectomy: 24 hours later. Urology. 1998 Feb;51(2):254-6.

6. Malloy TR, Sandhu JS, Smith AL, Reddy B, Harryhil JF, Kaplan SA, Te AE. Photoselective vaporization of the prostate (PVP) in anticoagulated patients: a multicenter retrospective evaluation of feasibility. J Urol 2005 Apr;173(4 suppl.):423 abstract 1562.

7. The management of benign prostatic hyperplasia: diagnosis and treatment recommendations. American Urological Association 2003.

8. Yakupoglu YK, Donmezer S, Mestci B, Saglam R, Simsek US. Successful treatment of BPH over 100 ml with KTP laser. J Urol 2006 May;175(4 suppl.):463 abstract 1522.

9. GreenLight Bibliography compiled by American Medical Systems updated 11/8/06.

10. Sarica K, Alkan E, Luleci H, Tasci AI. Photoselective vaporization of the enlarged prostate with KTP laser: long-term results in 240 patients. J Endourol. 2005 Dec;19(10):1199-202.

11. Mueller EJ. A series of 60 Greenlight photoselective vaporization of the prostate (PVP) patients with results equal to standard TURP with much decreased morbidity and much quicker return to full normal unrestricted activity. 52nd Annual James C Kimbrough Urological Seminar. Jan-16-Jan 21, 2005 Honolulu, Hawaii abstract 41.

12. Te AE, Malloy TR, Stein BS, Ulchaker JC, Nseyo UO, Hai MA. Impact of prostate-specific antigen level and prostate volume as predictors of efficacy in photoselective vaporization prostatectomy: analysis and results of an ongoing prospective multicentre study at 3 years. BJU Int. 2006 Jun;97(6):1229-33.

13. Bachmann A, Ruszat R, Wyler S, Reich O, Seifert HH, Muller A, Sulser T. Photoselective vaporization of the prostate: the basel experience after 108 procedures. Eur Urol. 2005 Jun;47(6):798-804. Epub 2005 Mar 2.

14. Reich O, Bachmann A, Siebels M, Hofstetter A, Stief CG, Sulser T. High power (80 W) potassium-titanyl-phosphate laser vaporization of the prostate in 66 high risk patients. J Urol. 2005 Jan;173(1):158-60.

15. Te AE, Malloy TR, Stein BS, Ulchaker JC, Nseyo UO, Hai MA, Malek RS. Photoselective vaporization of the prostate for the treatment of benign prostatic hyperplasia: 12-month results from the first United States multicenter prospective trial. J Urol. 2004 Oct;172(4 Pt 1):1404-8.

16. Sandhu JS, Ng C, Vanderbrink BA, Egan C, Kaplan SA, Te AE. High-power potassium-titanyl-phosphate photoselective laser vaporization of prostate for treatment of benign prostatic hyperplasia in men with large prostates. Urology. 2004 Dec;64(6):1155-9.

17. Sandhu JS, Ng CK, Gonzalez RR, Kaplan SA, Te AE. Photoselective laser vaporization prostatectomy in men receiving anticoagulants. J Endourol. 2005 Dec;19(10):1196-8.

18. Bouchier-Hayes DM, Anderson P, Van Appledorn S, Bugeja P, Costello AJ. A randomised trial comparing photoselective vaporization of the prostate (PVP) and transurethral resection of the prostate (TURP) in treatment of LUTS. J Urol 2006 May;175(4 suppl.):463 abstract 1433.

21. Bouchier-Hayes DM, Anderson P, Van Appledorn S, Bugeja P, Costello AJ.  A randomised trial comparing Photo-vaporisation and trans-urethral resection of the prostate in patients.  J Urol 2005 Apr;173(4 suppl): 421 abstract 1555.